|
Company
|
||||||
|---|---|---|---|---|---|---|
|
AbbVie
ABBV
|
NYSE
|
USA
|
Healthcare
|
218.04
$
|
-4.45
%
|
315.06B
$
|
|
Amgen
AMGN
|
NASDAQ
|
USA
|
Healthcare
|
298.43
$
|
2.2
%
|
141.01B
$
|
|
Gilead Sciences
GILD
|
NASDAQ
|
USA
|
Healthcare
|
118.44
$
|
1.14
%
|
115.92B
$
|
|
Vertex Pharmaceuticals
VRTX
|
NASDAQ
|
USA
|
Healthcare
|
419.89
$
|
1.35
%
|
103.86B
$
|
|
Genus PLC
GNS
|
LSE
|
UK
|
Healthcare
|
2.49K
£
|
-1.01
%
|
102.57B
£
|
|
Regeneron Pharmaceuticals
REGN
|
NASDAQ
|
USA
|
Healthcare
|
654.04
$
|
-0.34
%
|
81.99B
$
|
|
PROMOMED
PRMD
|
MOEX
|
Russia
|
Healthcare
|
374.1
₽
|
0.11
%
|
72.82B
₽
|
|
PureTech Health plc
PRTC
|
LSE
|
UK
|
Healthcare
|
134
£
|
-1.49
%
|
40.5B
£
|
|
argenx NV ADR
ARGX
|
NASDAQ
|
USA
|
Healthcare
|
820.36
$
|
-0.23
%
|
40.08B
$
|
|
Alnylam Pharmaceuticals
ALNY
|
NASDAQ
|
USA
|
Healthcare
|
449.56
$
|
1.44
%
|
30.04B
$
|
|
BioNTech SE
BNTX
|
NASDAQ
|
USA
|
Healthcare
|
104.67
$
|
-0.73
%
|
27.37B
$
|
|
Biodexa Pharmaceticals
BDRX
|
NASDAQ
|
USA
|
Healthcare
|
6.11
$
|
3.6
%
|
27.08B
$
|
|
Biogen
BIIB
|
NASDAQ
|
USA
|
Healthcare
|
149.61
$
|
3.11
%
|
22.31B
$
|
|
Natera
NTRA
|
NASDAQ
|
USA
|
Healthcare
|
193.22
$
|
2.96
%
|
19.74B
$
|
|
BeiGene, Ltd.
ONC
|
NASDAQ
|
USA
|
Healthcare
|
308.22
$
|
0.73
%
|
19.45B
$
|
|
4BASEBIO UK SOCIETAS
4BB
|
LSE
|
UK
|
Healthcare
|
790
£
|
-
|
18.72B
£
|
|
Artgen
ABIO
|
MOEX
|
Russia
|
Healthcare
|
66.16
₽
|
-0.7
%
|
17.41B
₽
|
|
United Therapeutics
UTHR
|
NASDAQ
|
USA
|
Healthcare
|
453.53
$
|
-1.79
%
|
17.11B
$
|
|
Avacta Group PLC
AVCT
|
LSE
|
UK
|
Healthcare
|
68
£
|
2.94
%
|
16.35B
£
|
|
Moderna
MRNA
|
NASDAQ
|
USA
|
Healthcare
|
28.14
$
|
-3.48
%
|
15.97B
$
|